Parkinson's Disease Trial, Recruiting NCT07353463 Sponsor: Ruijin Hospital Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07353463
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Parkinson's disease (PD) based on recognized Chinese diagnostic guidelines, OR you have been diagnosed with or are strongly suspected to have multiple system atrophy (MSA) based on recognized Chinese expert guidelines.
  • You are willing to provide samples of blood and saliva, and optionally a sample of spinal fluid, for research purposes.
  • You are willing to undergo brain scans (MRI and PET/SPECT imaging) and complete questionnaires or assessments related to your condition.
  • You are able and willing to sign a form confirming you understand and agree to take part in the study.

Who may not be able to join:

  • Your diagnosis is unclear or uncertain.
  • You have a history of stroke, a significant head injury, fluid build-up in the brain, a brain tumor, raised pressure in the skull, or have had brain surgery.
  • A brain scan (CT or MRI) has shown evidence of a physical abnormality or injury in the brain.
  • You have severe anxiety, severe depression, or schizophrenia.
  • You have serious problems with your heart, lungs, liver, kidneys, hormonal system, or blood conditions.
  • You have significant difficulty speaking or communicating in a way that would make it hard to complete the study assessments.
  • There are concerns that you may not be able to reliably follow the study requirements (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-021-64370045

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 April 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change from baseline in motor symptom severity assessed by MDS-UPDRS Part III; Change from baseline in Hoehn & Yahr stage; Change from baseline in Brief Pain Inventory (BPI) pain severity score; Change from baseline in REM Sleep Behavior Disorder Questionnaire-Hong Kong (RBDQ-HK) score; Change from baseline in International Restless Legs Syndrome Study Group Rating Scale (IRLSS) score; Change from baseline in University of Pennsylvania Smell Identification Test (UPSIT) score; Change from baseline in Scales for Outcomes in Parkinson's Disease-Autonomic (SCOPA-AUT) score; Change from baseline in...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov